These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Employing resource allocation modeling to inform HIV prevention planning for the state of Iowa. Holtgrave DR; Young PA; Mayer RR; Maulsby C; Kim JJ AIDS Educ Prev; 2013 Oct; 25(5):423-9. PubMed ID: 24059879 [TBL] [Abstract][Full Text] [Related]
44. Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992-2013. Williams LD; Ibragimov U; Tempalski B; Stall R; Satcher Johnson A; Wang G; Cooper HLF; Friedman SR Ann Epidemiol; 2020 May; 45():12-23. PubMed ID: 32439148 [TBL] [Abstract][Full Text] [Related]
45. Aligning resources to fight HIV/AIDS in the United States: funding to states through the US Department of Health and Human Services. Mansergh G; Valdiserri RO; Yakovchenko V; Koh H J Acquir Immune Defic Syndr; 2012 Apr; 59(5):516-22. PubMed ID: 22156922 [TBL] [Abstract][Full Text] [Related]
46. Vital signs: HIV testing and diagnosis among adults--United States, 2001-2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Dec; 59(47):1550-5. PubMed ID: 21124295 [TBL] [Abstract][Full Text] [Related]
47. Health Department HIV Prevention Programs That Support the National HIV/AIDS Strategy: The Enhanced Comprehensive HIV Prevention Planning Project, 2010-2013. Fisher HH; Hoyte T; Purcell DW; Van Handel M; Williams W; Krueger A; Dietz P; Stratford D; Heitgerd J; Dunbar E; Wan C; Linley LA; Flores SA Public Health Rep; 2016; 131(1):185-94. PubMed ID: 26843685 [TBL] [Abstract][Full Text] [Related]
48. Determining allocations for HIV-prevention interventions: assessing a change in federal funding policy. Valdiserri RO; Robinson C; Lin LS; West GR; Holtgrave DR AIDS Public Policy J; 1997; 12(4):138-48. PubMed ID: 10915267 [No Abstract] [Full Text] [Related]
50. Evaluation of HIV case surveillance through the use of non-name unique identifiers--Maryland and Texas, 1994-1996. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1998 Jan; 46(52-53):1254-8, 1271. PubMed ID: 9436716 [TBL] [Abstract][Full Text] [Related]
52. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. Hall HI; Frazier EL; Rhodes P; Holtgrave DR; Furlow-Parmley C; Tang T; Gray KM; Cohen SM; Mermin J; Skarbinski J JAMA Intern Med; 2013 Jul; 173(14):1337-44. PubMed ID: 23780395 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of CDC's Hemophilia Surveillance Program - Universal Data Collection (1998-2011) and Community Counts (2011-2019), United States. Schieve LA; Byams VR; Dupervil B; Oakley MA; Miller CH; Soucie JM; Abe K; Bean CJ; Hooper WC MMWR Surveill Summ; 2020 Sep; 69(5):1-18. PubMed ID: 32881847 [TBL] [Abstract][Full Text] [Related]
54. Teleconference on mandatory reporting and partner notification. Hoskins VM Body Posit; 1998 Mar; 11(3):18-23. PubMed ID: 11365248 [TBL] [Abstract][Full Text] [Related]
55. Human Immunodeficiency Virus Testing, Diagnosis, Linkage to Care, and Prevention Services Among Persons Who Inject Drugs, United States, 2012-2017. Rao S; Song W; Mulatu MS; Seena E; Essuon A; Heitgerd J J Infect Dis; 2020 Sep; 222(Suppl 5):S268-S277. PubMed ID: 32877556 [TBL] [Abstract][Full Text] [Related]
56. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Pappaioanou M; Dondero TJ; Petersen LR; Onorato IM; Sanchez CD; Curran JW Public Health Rep; 1990; 105(2):113-9. PubMed ID: 2157233 [TBL] [Abstract][Full Text] [Related]